NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 16, 2026 $5.05 -1.87% $5.16 X 97.94% 0
Apr 16, 2026 $5.09 -1.17% $5.16 X 98.64% 1
Apr 16, 2026 $5.25 +1.94% $5.16 V 98.26% 1
Jan 20, 2026 $6.25 -2.27% $5.92 V 94.34% 1
Jan 20, 2026 $6.31 -1.42% $5.92 V 93.42% 1
Jan 20, 2026 Bullish $5.92 X 0
Jul 10, 2025 Bullish $6.15 V 1
Jun 20, 2025 $5.01 +1.86% $4.75 X 94.50% 0
Jun 20, 2025 Bullish $4.75 X 0
@.93405
Jun 11, 2025 $6.09 +4.10% $5.46 X 88.46% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE